Caspian Healthcare  / Obesity

Caspian HealthcareObesity › Stopping

Stopping treatment without losing the ground

This is the question everyone asks last and should ask first. Almost no page in India or anywhere else gives an actual answer, so here is one, including the parts you will not like.

What happens if you just stop

Two trials answer this directly, and they answer it in the same direction.

two thirds
of the weight lost came back within a year of stopping. In the STEP-1 extension, 327 people followed for a year off treatment regained 11.6 of the 17.3 percentage points they had lost.
Wilding JPH et al, Diabetes Obesity and Metabolism, 2022
82%
regained more than a quarter of what they had lost. In SURMOUNT-4, people who reached minus 20.9 per cent and were then switched to placebo gained back 14.8 per cent over the following year, while those who continued reached minus 26.0 per cent.
JAMA 2023, and the cardiometabolic analysis in JAMA Internal Medicine 2025

And it is not only the weight. Waist, blood pressure, non-HDL cholesterol and fasting insulin all moved back towards where they started, roughly in proportion to how much weight came back. The metabolic benefit is rented, not bought.

The honest framing. Obesity behaves like high blood pressure. Nobody is surprised that blood pressure rises again when the tablet stops, and nobody calls that a failure of the tablet. This is the same. These are not treatments that reset a set point and then let you walk away. Plan for a long course, or plan a structured exit, but do not plan on a short course with a permanent result.

Then why does anyone stop?

Because they are real reasons. Cost, most commonly and by a long way. A planned pregnancy, which requires stopping about two months beforehand. Side effects that did not settle. Reaching a weight where the risk that justified the treatment has gone. Or simply having decided that indefinite treatment is not what they want, which is a legitimate choice for a patient to make.

Real world data are worth knowing here: somewhere between a third and a half of people are no longer on treatment at one year, and the dominant reasons are cost and supply rather than side effects. If you stop, you will be in ordinary company.

A structured stop

There is no trial telling us the best way to come off these treatments. Nobody has run it. What follows is a practical protocol built on what is known about how regain happens, and it is what we use. Treat it as considered clinical practice, not as proven fact.

  1. Do not stop from the top dose Step down through the doses rather than dropping off a cliff, spending four to six weeks at each. Appetite comes back gradually instead of all at once, which is the difference between managing it and being ambushed by it.
  2. Fix the protein and the training first, not afterwards Before the first reduction, the protein target should already be habitual and resistance training should already be happening twice a week. Muscle is what defends your resting energy expenditure, and you cannot build it during a taper. Anyone who has not done this work by the time they taper will regain faster.
  3. Expect hunger to return, and know what it is It is not weakness and it is not a relapse. It is the same defended physiology that made you heavy in the first place, uncovered again. Naming it in advance is genuinely protective.
  4. Weigh weekly, and set a line in advance Pick a number, usually two or three kilograms above where you finish, and decide now what happens if you cross it. A pre-agreed line turns a slow drift into a decision.
  5. Come back at three months, whatever is happening Not only if it goes wrong. The three month visit after stopping is when it is still easy to intervene. The visit people actually make is at twelve months, by which time most of the ground is gone.
  6. Restarting is not a failure If the weight and the risk come back, restarting is the correct clinical response, in the same way a blood pressure tablet is restarted. Coming back should not require an apology and will not receive a lecture.

What genuinely improves the odds

The reason this page exists at the point in the reading order that it does. Read it before starting, not at the end. If you know now that this is a long term commitment, you can make a very different and much better decision about which treatment to begin, what you can sustain, and whether to start at all. A treatment you can continue beats a better treatment you will have to stop.

Sources: STEP-1 extension, Wilding JPH et al, Diabetes, Obesity and Metabolism, 2022. SURMOUNT-4, JAMA, 2023, and the post-hoc cardiometabolic analysis, JAMA Internal Medicine, 2025. Joint nutrition advisory, 2025.

About the figures on this page

Every number here comes from a named, published clinical trial and is reported as what happened to the people in that trial. None of it is a result from this clinic, a prediction for you, or a promise. Trial populations are selected and individual results vary widely. The trials are named in the reference line above so that you, or any doctor, can look them up.

If you want to talk about what any of it means for your own situation, our contact details and consulting hours are at the bottom of every page in this section, and our fees are published in full on the cost page.